Portugal

BloodFlow: Artificial Intelligence Renews Blood Tests

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 12/11/2026, 15:16:24 UTC.

Briefings

A startup named BloodFlow, a finalist of the Global Tech Innovator 2026 competition organized by KPMG, uses artificial intelligence to revolutionize blood test analysis. The provided evidence indicates the company accelerates medical diagnoses but does not specify the number of patients processed, the accuracy percentage, or the specific date of the first successful diagnosis. The text cuts off mid-sentence, leaving details about the technology's performance metrics and the startup's operational timeline unknown.

Key points

• BloodFlow is a finalist of the Global Tech Innovator 2026 competition organized by KPMG.
• The startup uses artificial intelligence to revolutionize blood test analysis.

Context

BloodFlow is a finalist of the Global Tech Innovator 2026 competition organized by KPMG, a major global technology and innovation event. The startup aims to accelerate medical diagnoses using artificial intelligence, though specific performance metrics or operational dates are not detailed in the available text.

Limitations

The evidence is limited to a single sentence describing the startup's participation in a competition and its general use of AI for medical analysis. Specific numbers regarding patient volume, diagnostic accuracy, or the date of the first diagnosis are not provided, and the text ends abruptly without further details.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 12/11/2026, 15:17:30 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeibkjpsx2ccbgdu7alzuix662yu3lbfq3ocxrwu2utffghvhmu4rlm